Slaby O - Search Results

1

MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9.

Vychytilova-Faltejskova P, Merhautova J, Machackova T, Gutierrez-Garcia I, Garcia-Solano J, Radova L, Brchnelova D, Slaba K, Svoboda M, Halamkova J, Demlova R, Kiss I, Vyzula R, Conesa-Zamora P, Slaby O. Vychytilova-Faltejskova P, et al. Among authors: slaby o. Oncogenesis. 2017 Dec 4;6(11):399. doi: 10.1038/s41389-017-0006-6. Oncogenesis. 2017. PMID: 29199273 Free PMC article.

2

Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer.

Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M, Nenutil R, Vyzula R. Slaby O, et al. Oncology. 2007;72(5-6):397-402. doi: 10.1159/000113489. Epub 2008 Jan 15. Oncology. 2007. PMID: 18196926 Clinical Trial.

3

[Involvement of microRNAs in cancer biology and possibilities of their application to diagnostic and predictive oncology].

Slabý O, Krekác D, Hrstka R, Svoboda M, Vyzula R. Slabý O, et al. Cas Lek Cesk. 2008;147(1):25-31. Cas Lek Cesk. 2008. PMID: 18323039 Review. Czech.

4

Significant overexpression of Hsp110 gene during colorectal cancer progression.

Slaby O, Sobkova K, Svoboda M, Garajova I, Fabian P, Hrstka R, Nenutil R, Sachlova M, Kocakova I, Michalek J, Smerdova T, Knoflickova D, Vyzula R. Slaby O, et al. Oncol Rep. 2009 May;21(5):1235-41. doi: 10.3892/or_00000346. Oncol Rep. 2009. PMID: 19360299

5

[Possibilities of resistance prediction to neoadjuvant concomitant chemoradiotherapy in the treatment algorithm of patients with rectal carcinoma].

Garajová I, Svoboda M, Slabý O, Kocáková I, Fabian P, Kocák I, Vyzula R. Garajová I, et al. Among authors: slaby o. Klin Onkol. 2008;21(6):330-7. Klin Onkol. 2008. PMID: 19382596 Review. Slovak.

6

MicroRNA involvement in glioblastoma pathogenesis.

Novakova J, Slaby O, Vyzula R, Michalek J. Novakova J, et al. Among authors: slaby o. Biochem Biophys Res Commun. 2009 Aug 14;386(1):1-5. doi: 10.1016/j.bbrc.2009.06.034. Epub 2009 Jun 11. Biochem Biophys Res Commun. 2009. PMID: 19523920 Review.

7

[DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].

Slabý O, Svoboda M, Michálek J, Vyzula R. Slabý O, et al. Klin Onkol. 2009;22(5):202-9. Klin Onkol. 2009. PMID: 19886357 Review. Czech.

8

MicroRNAs in colorectal cancer: translation of molecular biology into clinical application.

Slaby O, Svoboda M, Michalek J, Vyzula R. Slaby O, et al. Mol Cancer. 2009 Nov 14;8:102. doi: 10.1186/1476-4598-8-102. Mol Cancer. 2009. PMID: 19912656 Free PMC article. Review.

9

MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients.

Slaby O, Lakomy R, Fadrus P, Hrstka R, Kren L, Lzicarova E, Smrcka M, Svoboda M, Dolezalova H, Novakova J, Valik D, Vyzula R, Michalek J. Slaby O, et al. Neoplasma. 2010;57(3):264-9. doi: 10.4149/neo_2010_03_264. Neoplasma. 2010. PMID: 20353279

10

Gene expression of somatostatin receptor 4 predicts clinical outcome of patients with metastatic neuroendocrine tumors treated with somatostatin analogs.

Slaby O, Sachlova M, Bednarikova M, Fabian P, Svoboda M, Vytopilova S, Valik D, Vyzula R. Slaby O, et al. Cancer Biother Radiopharm. 2010 Apr;25(2):237-43. doi: 10.1089/cbr.2009.0708. Cancer Biother Radiopharm. 2010. PMID: 20423238

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

360 results

Search Page

Filters